E3-ubiquitin ligases and recent progress in osteoimmunology

Yosuke Asano, Yoshinori Matsumoto, Jun Wada, Robert Rottapel

Research output: Contribution to journalShort surveypeer-review

11 Citations (Scopus)

Abstract

Ubiquitin-mediated proteasomal degradation is a post-transcriptional protein modification that is comprised of various components including the 76-amino acid protein ubiquitin (Ub), Ub-activating enzyme (E1), Ub-conjugating enzyme (E2), ubiquitin ligase (E3), deubiquitinating enzyme (DUB) and proteasome. We and others have recently provided genetic evidence showing that E3-ubiquitin ligases are associated with bone metabolism, the immune system and inflammation through ubiquitylation and subsequent degradation of their substrates. Dysregulation of the E3-ubiquitin ligase RNF146-mediated degradation of the adaptor protein 3BP2 (SH3 domain-binding protein 2) causes cherubism, an autosomal dominant disorder associated with severe inflammatory craniofacial dysmorphia syndrome in children. In this review, on the basis of our discoveries in cherubism, we summarize new insights into the roles of E3-ubiquitin ligases in the development of human disorders caused by an abnormal osteoimmune system by highlighting recent genetic evidence obtained in both human and animal model studies.

Original languageEnglish
Article number1120710
JournalFrontiers in immunology
Volume14
DOIs
Publication statusPublished - 2023

Keywords

  • E3-ubiquitin ligases
  • cherubism
  • osteoimmunology
  • proteasomal degradation
  • ubiquitylation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint

Dive into the research topics of 'E3-ubiquitin ligases and recent progress in osteoimmunology'. Together they form a unique fingerprint.

Cite this